Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy

European Journal of Endocrinology

Volumn 162, Issue 1, 2010, Pages 145-151

  Vannucchi, Guia ^a   Perrino, Michela ^a   Rossi, Stefania ^a   Colombo, Carla ^a   Vicentini, Leonardo ^b   Dazzi, Davide ^c   Beck Peccoz, Paolo ^a   Fugazzola, Laura ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c Ospedale di Fidenza   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CLINICAL FEATURE; CONTROLLED STUDY; DELIVERY; DIFFERENTIATED THYROID CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NULLIPARA; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PUERPERIUM; THYROID CANCER; THYROIDECTOMY; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; FOLLOW UP; GENETICS; PATHOLOGY; PHYSIOLOGY; PREGNANCY COMPLICATION; RETROSPECTIVE STUDY; THYROID TUMOR;

ADULT; CELL DIFFERENTIATION; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; RETROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 73949096862     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0761     Document Type: Article

References (31)

1. Smith LH, Danielsen B, Allen ME & Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. American Journal of Obstetrics and Gynecology 2003 189 1128-1135.
2. Knudsen N, Laurberg P, Perrild H, Bulow I, Ovesen L & Jorgensen T. Risk factors for goiter and thyroid nodules. Thyroid 2002 12 879-888.
3. Neale D & Burrow G. Thyroid disease in pregnancy. Obstetrics and Gynecology Clinics of North America 2004 31 893-905.
4. Hod M, Sharony R, Friedman S & Ovadia J. Pregnancy and thyroid carcinoma: a review of incidence, course, and prognosis. Obstetrical and Gynecological Survey 1989 44 774-779.
5. Kung AW, Chau MT, Lao TT, Tam SC & Low LC. The effect of pregnancy on thyroid nodule formation. Journal of Clinical Endocrinology and Metabolism 2002 87 1010-1014.
6. Yoshimura M & Hershman JM. Thyrotropic action of human chorionic gonadotropin. Thyroid 1995 5 425-434.
7. McTiernan AM,Weiss NS & Daling JR. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. American Journal of Epidemiology 1984 120 423-435.
8. Manole D, Schildknecht B, Gosnell B, Adams E & Derwahl M. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. Journal of Clinical Endocrinology and Metabolism 2001 86 1072-1077.
9. Zeng Q, Chen GG, Vlantis AC & van Hasselt CA. Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor - ERK pathway. Cell Proliferation 2007 40 921-935.
10. Hatae J, Takami N, Lin H, Honda A & Inoue R. 17β- Estradiolinduced enhancement of estrogen receptor biosynthesis via MAPK pathway in mouse skeletal muscle myoblasts. Journal of Physiological Sciences 2009 59 181-190.
11. Dalla Valle L, Ramina A, Vianello S, Fassina A, Belvedere P & Colombo L. Potential for estrogen synthesis and action in human normal and neoplastic thyroid tissues. Journal of Clinical Endocrinology and Metabolism 1998 83 3702-3709.
12. Bur M, Shiraki W & Masood S. Estrogen and progesterone receptor detection in neoplastic and non-neoplastic thyroid tissues. Modern Pathology 1993 6 469-472.
13. Inoue H, Oshimo K, Miki H, Kawano M & Monden Y. Immunohistochemical study of estrogen receptors and the responsiveness to estrogen in papillary thyroid carcinoma. Cancer 1993 72 1364-1368.
14. Hiasa Y, Nishioka H, Kitahori Y, Yane K, Nakaoka S, Ohshima M, Konishi N, Nishii K, Kitamura M & Matsunaga T. Immunohisto-chemical analysis of estrogen receptors in 313 paraffin section cases of human thyroid tissue. Oncology 1993 50 132-136.
15. Wang M, Pan JY, Song GR, Chen HB, An LJ & Qu SX. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters. European Journal of Surgical Oncology 2007 33 195-201.
16. Teng J, Wang ZY, Jarrard DF & Biorling DE. Roles of estrogen receptor α and β in modulating urothelial cell proliferation. Endocrine-Related Cancer 2008 15 351-364.
17. Fasco MJ, Hurteau GJ & Spivack SD. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Molecular and Cellular Endocrinology 2002 188 125-140.
18. Moosa M & Mazzaferri EL. Outcome of differentiated thyroid cancer diagnosed in pregnant women. Journal of Clinical Endocrinology and Metabolism 1997 82 2862-2866.
19. Yasmeen S, Cress R, Romano PS, Xing G, Berger-Chen S, Danielsen B & Smith LH. Thyroid cancer in pregnancy. International Journal of Gynaecology and Obstetrics 2005 91 15-20.
20. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW,Wiersinga W & European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. European Journal of Endocrinology 2006 154 787-803.
21. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI & Tuttle RM. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006 16 109-142.
22. Hedinger C. Histological Typing of Thyroid Tumors: WHO International Histological Classification of Tumors, edn 2. Berlin-Heidelberg-New York: Springer-Verlag, 1988.
23. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS & Nicoloff JT. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 1998 83 1121-1127.
24. Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, Grasso L & Pinchera A. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Annals of Internal Medicine 2003 139 346-351.
25. V600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocrine-Related Cancer 2006 13 455-464.
26. Xing M. BRAF mutation in thyroid cancer. Endocrine-Related Cancer 2005 12 245-262.
27. Arturi F, Russo D, Giuffrida D, Ippolito A, Perrotti N, Vigneri R & Filetti S. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. Journal of Clinical Endocrinology and Metabolism 1997 82 1638-1641.
28. Perrino M, Vannucchi G, Vicentini L, Cantoni G, Dazzi D, Colombo C, Rodari M, Chiti A, Beck-Peccoz P & Fugazzola L. Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers < or = 2 cm. Endocrine-Related Cancer 2009 16 201-210.
29. Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, Leone S, Trentalance A, Maramatsu M & Marino M. Survival versus apoptotic 17beta-estradiol effect: role of the ER alpha and ER beta activated non-genomic signalling. Journal of Cellular Physiology 2005 203 193-201.
30. Fagin JA & Mitsiades N. Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Practice & Research. Clinical Endocrinology & Metabolism 2008 22 955-969.
31. Driggers PH & Segars JH. Estrogen action and cytoplasmic signaling pathways, Part II: the role of growth factors and phosphorylation in estrogen signalling. Trends in Endocrinology and Metabolism 2002 13 422-427.